| abstract |
The present application relates to an Apolar Picrorhiza Extract (PE) of one or more plants selected from the group consisting of Picrorhiza kurroa, Neopicrorhiza scrophulariiflora, and Picrorhiza scrophulariiflora Pennell for prevention, treatment and management of primary and metastatic cancers and tumours, and associated inflammation. PE is also useful for safe and effective treatment and management for paediatric and geriatric primary and metastatic cancers and tumours. |